| 000 | 01845cam a22003614a 4500 | ||
|---|---|---|---|
| 001 | 13773169 | ||
| 003 | OSt | ||
| 005 | 20161117132933.0 | ||
| 008 | 041104s2006 nyua b 001 0 eng | ||
| 010 |
_a 2004063122 _z 2005050545 |
||
| 016 | 7 |
_a101258215 _2DNLM |
|
| 020 | _a0071422803 | ||
| 035 | _a(OCoLC)ocm56982354 | ||
| 040 |
_aDLC _cDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRM300 _b.G644 2006 |
| 060 | 0 | 0 | _a2005 L-513 |
| 060 | 1 | 0 |
_aQV 4 _bG6532 2006 |
| 082 | 0 | 0 | _aWB 300 G621l 2006 |
| 084 | _2bcl | ||
| 100 |
_aBrunton, L. Lawrence; Lazo, John S.; Parker, Keith L. _911302 |
||
| 245 | 0 | 0 | _aGoodman & Gilman's the pharmacological basis of therapeutics. |
| 250 | _a11th ed. | ||
| 260 |
_aNew York : _bMcGraw-Hill, _cc2006. |
||
| 300 |
_axxiii, 2021 p. : _bill. ; _c26 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | 0 |
_gSect. I _tGeneral principles -- _gSect. II _tDrugs acting at synaptic and neuroeffector junctional sites -- _gSect. III _tDrugs acting on the central nervous system -- _gSect. IV _tAutacoids: drug therapy of inflammation -- _gSect. V _tDrugs affecting renal and cardiovascular function -- _gSect. VI _tDrugs affecting gastrointestinal function -- _gSect. VII _tChemotherapy of parasitic infections -- _gSect. VIII _tChemotherapy of microbial diseases -- _gSect. IX _tChemotherapy of neoplastic diseases -- _gSect. X _tImmunomodulators -- _gSect. XI _tDrugs acting on the blood and the blood-forming organs -- _gSect. XII _tHormones and hormone antagonists -- _gSect. XIII _tDermatology -- _gSect. XIV _tOphthalmology -- _gSect. XV _tToxicology -- _tAppendices. |
| 650 | 0 |
_aPharmacology. _9357 |
|
| 650 | 0 |
_aTherapeutics. _91626 |
|
| 856 | 4 | 1 |
_3Table of contents only _uhttp://www.loc.gov/catdir/enhancements/fy0645/2004063122-t.html |
| 906 |
_a7 _bcbc _corignew _d1 _eocip _f20 _gy-gencatlg |
||
| 942 |
_2z _cSLOAN |
||
| 999 |
_c889 _d889 |
||